Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Polyethyleneglycol3350 vs Tegaserod in Treatment of Patients With Chronic Constipation

ClinicalTrials.gov ID: NCT00153140

Public ClinicalTrials.gov record NCT00153140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and efficacy of extended polyethyleneglycol3350 use to tegaserod in patients with chronic constipation.

Study identification

NCT ID
NCT00153140
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Braintree Laboratories
Industry
Enrollment
239 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2004 (Type not available)
Primary completion
Oct 2004 (Actual)
Completion
Not listed
Last update posted
Feb 7, 2013

Started 2004

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Not listed Mobile Alabama 36693 —
Not listed Glendale Arizona 85306 —
Not listed Anaheim California 92801 —
Not listed Sacramento California 95825 —
Not listed San Diego California 92103 —
Not listed Lake Worth Florida 33461 —
Not listed Largo Florida 33770 —
Not listed St. Petersburg Florida 33707 —
Not listed Laurel Maryland 20707 —
Not listed Brighton Massachusetts 02135 —
Not listed St Louis Missouri 63017 —
Not listed Raleigh North Carolina 27609 —
Not listed Raleigh North Carolina 27612 —
Not listed Winston-Salem North Carolina 27103 —
Not listed Cincinnati Ohio 45236 —
Not listed Greer South Carolina 29651 —
Not listed Memphis Tennessee 38120 —
Not listed Austin Texas 78705 —
Not listed Dallas Texas 75234 —
Not listed Fort Worth Texas 76135 —
Not listed San Angelo Texas 76904 —
Not listed Salt Lake City Utah 84121 —
Not listed Newport News Virginia 23606 —
Not listed Norfolk Virginia 23502 —
Not listed Richmond Virginia 23294 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00153140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 7, 2013 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00153140 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →